Congress trades

Abiomed, Inc. (ABMD)

NASDAQ · Healthcare · 33 congress trades · last filed 4 years agono longer trading under this ticker

20
Congress disclosures shown
28d
Median delay on the congress disclosures
of the 45 day limit
12 buys·8 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades ABMD.

Free on iOS and Android.

About Abiomed, Inc.

from the company's filings and listing, as of Oct 23, 2026
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Devices
Chief executive
-
Employees
2,003
Listed since
Jul 29, 1987
Market value
$17.2Blast quoted Dec 21, 2022
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-
Dividend yield
-

www.heartrecovery.com

Earnings

6 reported quarters
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2023reported Nov 1, 2022$1.30$1.04$265.9Mn/aEPS beatRevenue n/a
Q1 FY2023reported Aug 4, 2022$1.25$1.06$277.1Mn/aEPS beatRevenue n/a
Q4 FY2022reported Apr 28, 2022$1.16$1.09$269.9M$252.5MEPS beatRevenue beat
Q3 FY2022reported Feb 3, 2022$1.13$0.95$261.2M$266.8MEPS beatRevenue miss
Q2 FY2022reported Oct 28, 2021$1.03$0.97$248.1M$251.6MEPS beatRevenue in line
Q1 FY2022reported Aug 4, 2021$1.41$1.05$252.6M$252.6MEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Know when the next ABMD filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in ABMD

20 disclosures of 33 on record · median 28d of the 45 allowed

Since the trade: the stock's move from the trade date to the last close under this ticker (Dec 21, 2022), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000+2.0%S&P 500 +4.1% · -2.1 pts vs S&P 500Nov 3, 2022Dec 6, 202233d
Josh GottheimerJointStockSale$1,001 - $15,000+44.2%After the saleS&P 500 -2.2% · +46.3 pts vs S&P 500Sep 14, 2022Oct 16, 202232d
Ro KhannaStockSale$1,001 - $15,000+69.6%After the saleS&P 500 +5.3% · +64.3 pts vs S&P 500Jun 16, 2022Jul 7, 202221d
Ro KhannaStockSale$1,001 - $15,000+65.8%After the saleS&P 500 +5.0% · +60.8 pts vs S&P 500Jun 17, 2022Jul 7, 202220d
Ro KhannaStockPurchase$1,001 - $15,000+60.3%S&P 500 -3.2% · +63.6 pts vs S&P 500May 10, 2022Jun 10, 202231d
Ro KhannaStockPurchase$1,001 - $15,000+52.9%S&P 500 -2.7% · +55.6 pts vs S&P 500May 23, 2022Jun 10, 202218d
Ro KhannaStockSale$1,001 - $15,000+27.1%After the saleS&P 500 -12.2% · +39.4 pts vs S&P 500Apr 11, 2022May 6, 202225d
Ro KhannaStockPurchase$1,001 - $15,000+31.2%S&P 500 -12.1% · +43.3 pts vs S&P 500Feb 14, 2022Mar 8, 202222d
Ro KhannaStockPurchase$1,001 - $15,000+19.4%S&P 500 -17.8% · +37.2 pts vs S&P 500Jan 11, 2022Feb 8, 202228d
Ro KhannaStockPurchase$1,001 - $15,000+25.1%S&P 500 -11.9% · +37.0 pts vs S&P 500Jan 21, 2022Feb 8, 202218d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+25.3%S&P 500 +5.1% · +20.3 pts vs S&P 500Dec 23, 2020Jan 11, 202119d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+17.5%S&P 500 +3.3% · +14.3 pts vs S&P 500Dec 31, 2020Jan 11, 202111d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+29.2%S&P 500 +16.0% · +13.2 pts vs S&P 500Aug 11, 2020Sep 14, 202034d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+51.9%After the saleS&P 500 +21.0% · +30.9 pts vs S&P 500Jun 10, 2020Jul 17, 202037d
Ro KhannaStockSale$1,001 - $15,000+149.4%After the saleS&P 500 +45.7% · +103.7 pts vs S&P 500Apr 7, 2020May 13, 202036d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+138.0%S&P 500 +38.8% · +99.2 pts vs S&P 500Apr 9, 2020May 13, 202034d
Gilbert Ray Cisneros, Jr.StockPurchase$15,001 - $50,000+104.5%S&P 500 +20.0% · +84.5 pts vs S&P 500Jan 31, 2020Feb 18, 202018d
Josh GottheimerJointStockPurchase$1,001 - $15,000+101.5%S&P 500 +18.6% · +82.9 pts vs S&P 500Jan 10, 2020Feb 10, 202031d
Josh GottheimerJointStockSale$1,001 - $15,000+112.0%After the saleS&P 500 +23.2% · +88.8 pts vs S&P 500Dec 10, 2019Jan 6, 202027d
Ro KhannaStockSale$1,001 - $15,000+43.8%After the saleS&P 500 +30.8% · +13.0 pts vs S&P 500Jul 1, 2019Aug 6, 201936d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

Every Congress trade in ABMD, filterable by party, chamber, type and account.

Questions

Which members of Congress have traded ABMD?

Ro Khanna, Josh Gottheimer and Gilbert Ray Cisneros, Jr. disclosed ABMD transactions in the filings shown here.

How quickly are ABMD trades disclosed?

Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members

See every company we track